[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Historical Information on Olanzapine/Fluoxetine (marketed as Symbyax)

These items are out-of-date.
For current information on olanzapine/fluoxetine (marketed as Symbyax), click on http://www.fda.gov/cder/drug/infopage/olanzapine_fluoxetine/default.htm
  • Public Health Advisory: Deaths with Antipsychotics in Elderly Patients with Behavioral Disturbances. (4/11/2005)
  • FDA Talk Paper: FDA Issues Public Health Advisory for Antipsychotic Drugs used for Treatment of Behavioral Disorders in Elderly Patients. (4/11/2005)

Back to Top     Back to Symbyax

PDF requires the free Adobe Acrobat Reader

Date created: July 19, 2006

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA/Center for Drug Evaluation and Research